This study of SARS-CoV-2 mRNA vaccination in 14 persons with HIV (PWH) demonstrated uniformly high anti-SARS-CoV-2 receptor binding domain (RBD) antibody titres after two doses, despite varied titres after a single dose. The majority of vaccine reactions were mild and no adverse events occurred.
|Original language||English (US)|
|Number of pages||3|
|Journal||AIDS (London, England)|
|State||Published - Nov 15 2021|
ASJC Scopus subject areas
- Immunology and Allergy
- Infectious Diseases